Literature DB >> 9722037

Postoperative plasma concentrations of procalcitonin after different types of surgery.

M Meisner1, K Tschaikowsky, A Hutzler, C Schick, J Schüttler.   

Abstract

OBJECTIVE: Procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations were measured after different types of surgery to analyze a possible postoperative induction of procalcitonin (PCT), which might interfere with the diagnosis of bacterial infection or sepsis by PCT.
DESIGN: PCT and CRP plasma levels as well as clinical symptoms of infection were prospectively registered preoperatively and 5 days postoperatively.
SETTING: University hospital, in-patient postoperative care. PATIENTS: Hundred thirty patients were followed up; 117 patients with a normal postoperative course were statistically analyzed.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: PCT concentrations were moderately increased above the normal range in 32 % of patients after minor and aseptic surgery, in 59 % after cardiac and thoracic surgery, and in 95 % of patients after surgery of the intestine. In patients with an abnormal postoperative course, PCT was increased in 12 of 13 patients. CRP was increased in almost all patients.
CONCLUSIONS: Postoperative induction of PCT largely depends on the type of surgery. Intestinal surgery and major operations more often increase PCT, whereas it is normal in the majority of patients after minor and primarily aseptic surgery. PCT can thus be used postoperatively for diagnostic means only when the range of PCT concentrations during the normal course of a certain type of surgery is considered and concentrations are followed up.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722037     DOI: 10.1007/s001340050644

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  6 in total

1.  Procalcitonin and C-reactive protein levels in neonatal infections.

Authors:  G Monneret; J M Labaune; C Isaac; F Bienvenu; G Putet; J Bienvenu
Journal:  Acta Paediatr       Date:  1997-02       Impact factor: 2.299

2.  Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury.

Authors:  H Carsin; M Assicot; F Feger; O Roy; I Pennacino; H Le Bever; P Ainaud; C Bohuon
Journal:  Burns       Date:  1997-05       Impact factor: 2.744

3.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

4.  Procalcitonin in diagnosis of severe infections.

Authors:  B Al-Nawas; I Krammer; P M Shah
Journal:  Eur J Med Res       Date:  1996-04-18       Impact factor: 2.175

5.  New aspects concerning the regulation of the post-operative acute phase reaction during cardiac surgery.

Authors:  D Berger; E Bölke; H Huegel; M Seidelmann; A Hannekum; H G Beger
Journal:  Clin Chim Acta       Date:  1995-08-14       Impact factor: 3.786

6.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

  6 in total
  87 in total

1.  Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction.

Authors:  T Buratti; G Ricevuti; C Pechlaner; M Joannidis; F J Wiedermann; D Gritti; M Herold; C J Wiedermann
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

Review 2.  Procalcitonin in acute cardiac patients.

Authors:  Claudio Picariello; Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-09-29       Impact factor: 3.397

3.  Effects of volumetric vs. pressure-guided fluid therapy on postoperative inflammatory response: a prospective, randomized clinical trial.

Authors:  Tamas Szakmany; Ildiko Toth; Zsolt Kovacs; Tamas Leiner; Andras Mikor; Tamas Koszegi; Zsolt Molnar
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

4.  Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study.

Authors:  Ansgar Michael Chromik; Frank Endter; Waldemar Uhl; Arnulf Thiede; Hans Bernd Reith; Ulrich Mittelkötter
Journal:  Langenbecks Arch Surg       Date:  2005-12-21       Impact factor: 3.445

Review 5.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

Review 6.  [Sepsis. Update on pathophysiology, diagnostics and therapy].

Authors:  M Bauer; F Brunkhorst; T Welte; H Gerlach; K Reinhart
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

7.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Increased serum levels of C-reactive protein precede anastomotic leakage in colorectal surgery.

Authors:  Guido Woeste; Christine Müller; Wolf O Bechstein; Christoph Wullstein
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

9.  Value of procalcitonin for diagnosing perioperative pneumonia, urinary infections and superficial surgical site infections in patients undergoing primary hip and knee arthroplasty.

Authors:  Lixuan Zhang; Daozhang Cai; Hanming Guo
Journal:  Exp Ther Med       Date:  2018-05-03       Impact factor: 2.447

Review 10.  [Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].

Authors:  K Reinhart; F Brunkhorst; H Bone; H Gerlach; M Gründling; G Kreymann; P Kujath; G Marggraf; K Mayer; A Meier-Hellmann; C Peckelsen; C Putensen; M Quintel; M Ragaller; R Rossaint; F Stüber; N Weiler; T Welte; K Werdan
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.